Shenzhen Chipscreen Biosciences Co., Ltd. (SHA:688321)
China · Delayed Price · Currency is CNY 30.19
-0.71 (-2.30%)
Mar 19, 2026, 3:00 PM CST
SHA:688321 Market Cap
SHA:688321 has a market cap or net worth of 13.69 billion as of March 18, 2026. Its market cap has increased by 86.25% in one year.
Market Cap
13.69B
Enterprise Value
14.60B
Revenue
909.54M
Ranking
n/a
PE Ratio
246.81
Stock Price
30.19
Market Cap Chart
Since August 12, 2019, SHA:688321's market cap has decreased from 39.08B to 13.69B, a decrease of -64.97%. That is a compound annual growth rate of -14.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 13.69B | 14.86% |
| Dec 31, 2025 | 11.92B | 57.27% |
| Dec 31, 2024 | 7.58B | -15.30% |
| Dec 29, 2023 | 8.95B | - |
| Dec 30, 2022 | 8.95B | -37.79% |
| Dec 31, 2021 | 14.38B | -5.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shenzhen Hepalink Pharmaceutical Group | 15.20B |
| Zhejiang Medicine | 15.12B |
| Zhejiang Jiuzhou Pharmaceutical | 14.74B |
| ApicHope Pharmaceutical Group | 14.74B |
| Shanghai Shyndec Pharmaceutical | 14.44B |
| Shanghai Haoyuan Chemexpress | 14.36B |
| Tibet Rhodiola Pharmaceutical Holding Co. | 14.13B |
| Beijing Aosaikang Pharmaceutical | 13.63B |